← Back to Search

Behavioural Intervention

Community Mental Health Intervention for Latino Mental Health Disparities

N/A

Recruiting

Research Sponsored by Drexel University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 18-65

Moderate to severe clinical symptoms of anxiety, depression, and/or PTSD

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial seeks to reduce mental health disparities among Latinos in the U.S. by developing and testing a culturally-appropriate intervention to improve mental health.

Who is the study for?

CRISOL Mente is for Latinos aged 18-65 living in specific counties around Philadelphia who self-identify as Latino and have moderate to severe anxiety, depression, or PTSD. It's not for those with high-risk mental health issues, current therapy participants, or pregnant individuals.

What is being tested?

The trial tests CRISOL Mente, a community-based program aiming to improve access to mental health services among Latinos through outreach programs and culturally-tailored care strategies.

What are the potential side effects?

Since this intervention involves non-medical community support and navigation rather than drugs or medical procedures, typical side effects associated with medications are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Select...

I experience moderate to severe symptoms of anxiety, depression, or PTSD.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Improvement in mental health symptomatology (depressive, anxiety or post-traumatic stress disorder [PTSD])

Secondary study objectives

Anxiety symptomatology

Depressive symptomatology

Post traumatic stress disorder symptomatology

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Group I: LHW stepped care and task shiftingExperimental Treatment3 Interventions

LHW conduct activities of prior arms but in addition, they may provide specific components of mental health care (task-shifting), providing components of basic evidence-based treatments to patients with non-complex needs, and addressing other syndemic health and social conditions.

Group II: LHW as outreach agents/navigatorsExperimental Treatment1 Intervention

Conduct outreach activities with people in the community who are hard to reach and with limited access to health care, conduct screening for symptoms of mental illnesses, encourage and refer individuals at-risk, suspected of having, or affected by mental health issues for further triage.

Group III: LHW as navigators and auxiliary to careExperimental Treatment2 Interventions

LHW continue conducting outreach and referral activities but in addition, LHW are more involved in their care. They arrange consultations, introduce the patient to the clinical team via a "warm hand-off" and assist in scheduling a follow -up visit, reviews the care plan with the patient and help reduce patient and system barriers impeding psychological well-being, support patients in achieving management goals; help patients address barriers through education, referral, and navigation to ancillary community services. They have frequent contact with the patient.

0 / 2Eligibility criteria met